Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215098
Status:
TERMINATED
Last Update Posted:
2012-03-16
First Post:
2005-09-20
Brief Title:
Chylothorax Following Heart Surgery
Sponsor:
Childrens Healthcare of Atlanta
Organization:
Childrens Healthcare of Atlanta
Study Overview
Official Title:
Chylothorax in Children Following Congenital Heart Surgery
Status:
TERMINATED
Status Verified Date:
2007-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
insufficient data
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine at risk populations for certain congenital heart defects or certain operative procedures and to define the associated morbidity secondary to chylothorax - prolonged chest tube drainage prolonged hospital stay need for central access and hyperalimentation subsequent infection
Detailed Description:
Chylothorax is not uncommon following congenital heart surgery It often results in prolonged chest tube drainage and hospital stays Due to the feeding difficulties it often results in malnutrition and the need for central hyperalimentation In addition it results in a depressed immune system with the possibility of subsequent infection Chylothorax can be a significant contributor to post-operative morbidity and mortality
The primary aims are to determine at risk populations - certain congenital heart defects or certain operative procedures to define the associated morbidity secondary to chylothorax - prolonged chest tube drainage prolonged hospital stay need for central access and hyperalimentation subsequent infection and to review our current treatment methods - change formulas hyperalimentation somatostatin The secondary aims are to determine ways to prevent chylothorax determine the most successful treatment method and to discover better treatment methods This study will be conducted through a retrospective chart review
The primary aims are to determine at risk populations - certain congenital heart defects or certain operative procedures to define the associated morbidity secondary to chylothorax - prolonged chest tube drainage prolonged hospital stay need for central access and hyperalimentation subsequent infection and to review our current treatment methods - change formulas hyperalimentation somatostatin The secondary aims are to determine ways to prevent chylothorax determine the most successful treatment method and to discover better treatment methods This study will be conducted through a retrospective chart review
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None